Delivery Order SPE2DB25D3404-SPE2DB25FUMNZ
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S, a medical product, with a ceiling value of $4,510.68 and a completion date of July 8, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,503.56, is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S, a medical product. The contract is designated as a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,212.90 firm fixed-price delivery order is for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S, with a performance period extending through June 4, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 2-packs of ZYMFENTRA 120 MG/ML PEN, a pharmaceutical product. The contract has a ceiling value of $2,106.45 and is a firm fixed price delivery order. The award date is June 9, 2025 and the ultimate completion date is July 1, 2025. This contract is not set aside and is therefore open to competition. Amerisourcebergen Drug...
- This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN KITS, a medical product, with a firm fixed price of $1,503.56 and a completion date of June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a $1,503.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S. The order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows Amerisourcebergen to supply a wide range of...
- This federal contract award is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S medical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $3,007.12. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 28, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,503.56, is a delivery order for ZYMFENTRA 120 MG/ML PEN (2PK)S, a pharmaceutical product. The contract is not set aside and is a firm fixed price delivery order. Amerisourcebergen Drug Corp is the prime contractor and there is no information provided on any subcontractors. This contract is part of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S. The firm-fixed-price contract, valued at $3,007.12, has an ultimate completion date of August 1, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military...
- This is a $6,014.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S medical products, with a performance period through April 16, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUMNZDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S, a pharmaceutical product, under a Firm Fixed Price contract with a ceiling value of $1,503.56 and a period of performance through April 8, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 3/18/25 |